Head And Neck Cancer – Pipeline Review, H2 2016

Global Markets Direct’s, ‘Head And Neck Cancer – Pipeline Review, H2 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head And Neck Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer

The report reviews pipeline therapeutics for Head And Neck Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Head And Neck Cancer therapeutics and enlists all their major and minor projects

The report assesses Head And Neck Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Head And Neck Cancer

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Head And Neck Cancer

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Head And Neck Cancer pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

3SBio Inc.

4SC AG

AB Science SA

AbbVie Inc

Accelerated Pharma, Inc.

Acceleron Pharma, Inc.

Adaptimmune Therapeutics Plc

Aduro BioTech, Inc.

Advaxis, Inc.

Advenchen Laboratories, LLC

Affimed GmbH

Alchemia Limited

Altor BioScience Corporation

Ambrx, Inc.

Amgen Inc.

arGEN-X BV

ArQule, Inc.

Aspyrian Therapeutics, Inc.

Astellas Pharma Inc.

AstraZeneca Plc

Atara Biotherapeutics, Inc.

ATLAB Pharma SAS

Aura Biosciences, Inc.

AVEO Pharmaceuticals, Inc.

Bayer AG

Betta Pharmaceuticals Co. Ltd.

Bexion Pharmaceuticals, LLC

Bio-Path Holdings, Inc.

BioDiem Ltd

Biomics Biotechnologies Co., Ltd.

Bionovis SA

BioNTech AG

Biotest AG

Boehringer Ingelheim GmbH

Boston Biomedical, Inc.

Bristol-Myers Squibb Company

Calithera Biosciences, Inc.

CEL-SCI Corporation

Celgene Corporation

Cell Medica Limited

Cellceutix Corporation

Celldex Therapeutics, Inc.

Celprogen, Inc.

Centrose LLC

Corvus Pharmaceuticals, Inc.

Cristal Therapeutics B.V.

Critical Outcome Technologies Inc.

CTI BioPharma Corp.

Daiichi Sankyo Company, Limited

DNJ Pharma, Inc.

Eisai Co., Ltd.

Eleven Biotherapeutics Inc.

Eli Lilly and Company

EntreChem, S.L.

Etubics Corporation

Eureka Therapeutics, Inc.

F. Hoffmann-La Roche Ltd.

Five Prime Therapeutics, Inc.

G&E Herbal Biotechnology Co., Ltd.

Genelux Corporation

GeneSegues Inc

Genexine, Inc.

Genmab A/S

Genticel S.A.

GlaxoSmithKline Plc

Gliknik, Inc.

Glycotope GmbH

Hanmi Pharmaceuticals, Co. Ltd.

Hookipa Biotech AG

Horizon Pharma Plc

Hutchison MediPharma Limited

Ignyta, Inc.

Immunomedics, Inc.

Immunovaccine, Inc.

Immunovative Therapies, Ltd.

Incuron, LLC

Incyte Corporation

Infinity Pharmaceuticals, Inc.

Innate Pharma S.A.

Inovio Pharmaceuticals, Inc.

InteRNA Technologies B.V.

IRX Therapeutics, Inc.

ISA Pharmaceuticals B.V.

Jiangsu Kanion Pharmaceutical Co., Ltd.

Johnson & Johnson

Kite Pharma Inc

Kolltan Pharmaceuticals, Inc.

Kura Oncology, Inc.

Laboratoires Pierre Fabre SA

Lakewood-Amedex Inc

Loxo Oncology, Inc.

Lytix Biopharma AS

Mabion SA

Mabtech Limited

MacroGenics, Inc.

Marsala Biotech Inc.

Mateon Therapeutics Inc

MaxiVAX SA

Meabco A/S

MedImmune, LLC

Merck & Co., Inc.

Merck KGaA

Merrimack Pharmaceuticals, Inc.

Millennium Pharmaceuticals Inc

Mirati Therapeutics Inc.

Molecular Partners AG

Moleculin Biotech Inc

Molplex Ltd.

NanoCarrier Co., Ltd.

Natco Pharma Limited

Neonc Technologies Inc

Northwest Biotherapeutics, Inc.

Novartis AG

Omnitura Therapeutics Inc.

Oncobiologics, Inc.

Oncolys BioPharma Inc

Oncolytics Biotech Inc.

Onconova Therapeutics, Inc.

OncoSec Medical Incorporated

Ono Pharmaceutical Co., Ltd.

Oryx GmbH & Co. KG

Panacea Biotec Limited

PCI Biotech Holding ASA

PDS Biotechnology Corporation

Pfizer Inc.

Pharma Mar, S.A.

Pique Therapeutics

PlantForm Corporation

Plexxikon Inc.

PNP Therapeutics, Inc.

Profectus BioSciences, Inc.

ProNAi Therapeutics, Inc.

Provectus Biopharmaceuticals, Inc.

R-Pharm

Redx Pharma Plc

Reliance Life Sciences Pvt. Ltd.

Sanofi

Sapvax

Sareum Holdings Plc

Selecta Biosciences, Inc.

Shanghai Henlius Biotech Co., Ltd.

Shenzen SiBiono GeneTech Co., Ltd.

Shionogi & Co., Ltd.

Silence Therapeutics Plc

Sillajen Biotherapeutics

Sinil Pharmaceutical Co., Ltd

SuviCa Inc.

Symphogen A/S

SynCore Biotechnology Co., Ltd.

Taiwan Liposome Company, Ltd.

Takara Bio Inc.

Takis S.r.l.

Tara Immuno-Oncology Therapeutics LLC

Tessa Therapeutics Pte Ltd

Theravectys SA

Tolero Pharmaceuticals, Inc.

TyrNovo Ltd.

UbiVac, LLC

Vaccibody AS

VasGene Therapeutics, Inc.

Vault Pharma Inc.

Vaxeal Holding SA

VentiRx Pharmaceuticals, Inc.

Virttu Biologics Limited

VLPbio

VM Discovery, Inc.

Vyriad Inc

Yabao Pharmaceutical Group Co., Ltd.

Table of Contents

Table of Contents

Table of Contents 2

Introduction 9

Head And Neck Cancer Overview 10

Therapeutics Development 11

Head And Neck Cancer - Therapeutics under Development by Companies 13

Head And Neck Cancer - Therapeutics under Investigation by Universities/Institutes 27

Head And Neck Cancer - Pipeline Products Glance 29

Head And Neck Cancer - Products under Development by Companies 33

Head And Neck Cancer - Products under Investigation by Universities/Institutes 54

Head And Neck Cancer - Companies Involved in Therapeutics Development 57

Head And Neck Cancer - Therapeutics Assessment 225

Drug Profiles 260

Head And Neck Cancer - Dormant Projects 1081

Head And Neck Cancer - Discontinued Products 1097

Head And Neck Cancer - Product Development Milestones 1100

Appendix 1119

List of Tables

List of Tables

Number of Products under Development for Head And Neck Cancer, H2 2016 44

Number of Products under Development for Head And Neck Cancer – Comparative Analysis, H2 2016 45

Number of Products under Development by Companies, H2 2016 46

Number of Products under Development by Companies, H2 2016 (Contd..1) 47

Number of Products under Development by Companies, H2 2016 (Contd..2) 48

Number of Products under Development by Companies, H2 2016 (Contd..3) 49

Number of Products under Development by Companies, H2 2016 (Contd..4) 50

Number of Products under Development by Companies, H2 2016 (Contd..5) 51

Number of Products under Development by Companies, H2 2016 (Contd..6) 52

Number of Products under Development by Companies, H2 2016 (Contd..7) 53

Number of Products under Development by Companies, H2 2016 (Contd..8) 54

Number of Products under Development by Companies, H2 2016 (Contd..9) 55

Number of Products under Development by Companies, H2 2016 (Contd..10) 56

Number of Products under Development by Companies, H2 2016 (Contd..11) 57

Number of Products under Development by Companies, H2 2016 (Contd..12) 58

Number of Products under Development by Companies, H2 2016 (Contd..13) 59

Number of Products under Investigation by Universities/Institutes, H2 2016 60

Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 61

Comparative Analysis by Late Stage Development, H2 2016 62

Comparative Analysis by Clinical Stage Development, H2 2016 63

Comparative Analysis by Early Stage Development, H2 2016 64

Comparative Analysis by Unknown Stage Development, H2 2016 65

Products under Development by Companies, H2 2016 66

Products under Development by Companies, H2 2016 (Contd..1) 67

Products under Development by Companies, H2 2016 (Contd..2) 68

Products under Development by Companies, H2 2016 (Contd..3) 69

Products under Development by Companies, H2 2016 (Contd..4) 70

Products under Development by Companies, H2 2016 (Contd..5) 71

Products under Development by Companies, H2 2016 (Contd..6) 72

Products under Development by Companies, H2 2016 (Contd..7) 73

Products under Development by Companies, H2 2016 (Contd..8) 74

Products under Development by Companies, H2 2016 (Contd..9) 75

Products under Development by Companies, H2 2016 (Contd..10) 76

Products under Development by Companies, H2 2016 (Contd..11) 77

Products under Development by Companies, H2 2016 (Contd..12) 78

Products under Development by Companies, H2 2016 (Contd..13) 79

Products under Development by Companies, H2 2016 (Contd..14) 80

Products under Development by Companies, H2 2016 (Contd..15) 81

Products under Development by Companies, H2 2016 (Contd..16) 82

Products under Development by Companies, H2 2016 (Contd..17) 83

Products under Development by Companies, H2 2016 (Contd..18) 84

Products under Development by Companies, H2 2016 (Contd..19) 85

Products under Development by Companies, H2 2016 (Contd..20) 86

Products under Investigation by Universities/Institutes, H2 2016 87

Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88

Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 89

Head And Neck Cancer – Pipeline by 3SBio Inc., H2 2016 90

Head And Neck Cancer – Pipeline by 4SC AG, H2 2016 91

Head And Neck Cancer – Pipeline by AB Science SA, H2 2016 92

Head And Neck Cancer – Pipeline by AbbVie Inc, H2 2016 93

Head And Neck Cancer – Pipeline by Accelerated Pharma, Inc., H2 2016 94

Head And Neck Cancer – Pipeline by Acceleron Pharma, Inc., H2 2016 95

Head And Neck Cancer – Pipeline by Adaptimmune Therapeutics Plc, H2 2016 96

Head And Neck Cancer – Pipeline by Aduro BioTech, Inc., H2 2016 97

Head And Neck Cancer – Pipeline by Advaxis, Inc., H2 2016 98

Head And Neck Cancer – Pipeline by Advenchen Laboratories, LLC, H2 2016 99

Head And Neck Cancer – Pipeline by Affimed GmbH , H2 2016 100

Head And Neck Cancer – Pipeline by Alchemia Limited, H2 2016 101

Head And Neck Cancer – Pipeline by Altor BioScience Corporation, H2 2016 102

Head And Neck Cancer – Pipeline by Ambrx, Inc., H2 2016 103

Head And Neck Cancer – Pipeline by Amgen Inc., H2 2016 104

Head And Neck Cancer – Pipeline by arGEN-X BV, H2 2016 105

Head And Neck Cancer – Pipeline by ArQule, Inc., H2 2016 106

Head And Neck Cancer – Pipeline by Aspyrian Therapeutics, Inc., H2 2016 107

Head And Neck Cancer – Pipeline by Astellas Pharma Inc., H2 2016 108

Head And Neck Cancer – Pipeline by AstraZeneca Plc, H2 2016 109

Head And Neck Cancer – Pipeline by Atara Biotherapeutics, Inc., H2 2016 110

Head And Neck Cancer – Pipeline by ATLAB Pharma SAS, H2 2016 111

Head And Neck Cancer – Pipeline by Aura Biosciences, Inc., H2 2016 112

Head And Neck Cancer – Pipeline by AVEO Pharmaceuticals, Inc., H2 2016 113

Head And Neck Cancer – Pipeline by Bayer AG, H2 2016 114

Head And Neck Cancer – Pipeline by Betta Pharmaceuticals Co. Ltd., H2 2016 115

Head And Neck Cancer – Pipeline by Bexion Pharmaceuticals, LLC, H2 2016 116

Head And Neck Cancer – Pipeline by Bio-Path Holdings, Inc., H2 2016 117

Head And Neck Cancer – Pipeline by BioDiem Ltd, H2 2016 118

Head And Neck Cancer – Pipeline by Biomics Biotechnologies Co., Ltd., H2 2016 119

Head And Neck Cancer – Pipeline by Bionovis SA, H2 2016 120

Head And Neck Cancer – Pipeline by BioNTech AG, H2 2016 121

Head And Neck Cancer – Pipeline by Biotest AG, H2 2016 122

Head And Neck Cancer – Pipeline by Boehringer Ingelheim GmbH, H2 2016 123

Head And Neck Cancer – Pipeline by Boston Biomedical, Inc., H2 2016 124

Head And Neck Cancer – Pipeline by Bristol-Myers Squibb Company, H2 2016 125

Head And Neck Cancer – Pipeline by Calithera Biosciences, Inc., H2 2016 126

Head And Neck Cancer – Pipeline by CEL-SCI Corporation, H2 2016 127

Head And Neck Cancer – Pipeline by Celgene Corporation, H2 2016 128

Head And Neck Cancer – Pipeline by Cell Medica Limited, H2 2016 129

Head And Neck Cancer – Pipeline by Cellceutix Corporation, H2 2016 130

Head And Neck Cancer – Pipeline by Celldex Therapeutics, Inc., H2 2016 131

Head And Neck Cancer – Pipeline by Celprogen, Inc., H2 2016 132

Head And Neck Cancer – Pipeline by Centrose LLC, H2 2016 133

Head And Neck Cancer – Pipeline by Corvus Pharmaceuticals, Inc., H2 2016 134

Head And Neck Cancer – Pipeline by Cristal Therapeutics B.V., H2 2016 135

Head And Neck Cancer – Pipeline by Critical Outcome Technologies Inc., H2 2016 136

Head And Neck Cancer – Pipeline by CTI BioPharma Corp., H2 2016 137

Head And Neck Cancer – Pipeline by Daiichi Sankyo Company, Limited, H2 2016 138

Head And Neck Cancer – Pipeline by DNJ Pharma, Inc., H2 2016 139

Head And Neck Cancer – Pipeline by Eisai Co., Ltd., H2 2016 140

Head And Neck Cancer – Pipeline by Eleven Biotherapeutics Inc., H2 2016 141

Head And Neck Cancer – Pipeline by Eli Lilly and Company, H2 2016 142

Head And Neck Cancer – Pipeline by EntreChem, S.L., H2 2016 143

Head And Neck Cancer – Pipeline by Etubics Corporation, H2 2016 144

Head And Neck Cancer – Pipeline by Eureka Therapeutics, Inc., H2 2016 145

Head And Neck Cancer – Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 146

Head And Neck Cancer – Pipeline by Five Prime Therapeutics, Inc., H2 2016 147

Head And Neck Cancer – Pipeline by G&E Herbal Biotechnology Co., Ltd., H2 2016 148

Head And Neck Cancer – Pipeline by Genelux Corporation, H2 2016 149

Head And Neck Cancer – Pipeline by GeneSegues Inc, H2 2016 150

Head And Neck Cancer – Pipeline by Genexine, Inc., H2 2016 151

Head And Neck Cancer – Pipeline by Genmab A/S, H2 2016 152

Head And Neck Cancer – Pipeline by Genticel S.A., H2 2016 153

Head And Neck Cancer – Pipeline by GlaxoSmithKline Plc, H2 2016 154

Head And Neck Cancer – Pipeline by Gliknik, Inc., H2 2016 155

Head And Neck Cancer – Pipeline by Glycotope GmbH, H2 2016 156

Head And Neck Cancer – Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2016 157

Head And Neck Cancer – Pipeline by Hookipa Biotech AG, H2 2016 158

Head And Neck Cancer – Pipeline by Horizon Pharma Plc, H2 2016 159

Head And Neck Cancer – Pipeline by Hutchison MediPharma Limited, H2 2016 160

Head And Neck Cancer – Pipeline by Ignyta, Inc., H2 2016 161

Head And Neck Cancer – Pipeline by Immunomedics, Inc., H2 2016 162

Head And Neck Cancer – Pipeline by Immunovaccine, Inc., H2 2016 163

Head And Neck Cancer – Pipeline by Immunovative Therapies, Ltd., H2 2016 164

Head And Neck Cancer – Pipeline by Incuron, LLC, H2 2016 165

Head And Neck Cancer – Pipeline by Incyte Corporation, H2 2016 166

Head And Neck Cancer – Pipeline by Infinity Pharmaceuticals, Inc., H2 2016 167

Head And Neck Cancer – Pipeline by Innate Pharma S.A., H2 2016 168

Head And Neck Cancer – Pipeline by Inovio Pharmaceuticals, Inc., H2 2016 169

Head And Neck Cancer – Pipeline by InteRNA Technologies B.V., H2 2016 170

Head And Neck Cancer – Pipeline by IRX Therapeutics, Inc., H2 2016 171

Head And Neck Cancer – Pipeline by ISA Pharmaceuticals B.V., H2 2016 172

Head And Neck Cancer – Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd., H2 2016 173

Head And Neck Cancer – Pipeline by Johnson & Johnson, H2 2016 174

Head And Neck Cancer – Pipeline by Kite Pharma Inc, H2 2016 175

Head And Neck Cancer – Pipeline by Kolltan Pharmaceuticals, Inc., H2 2016 176

Head And Neck Cancer – Pipeline by Kura Oncology, Inc., H2 2016 177

Head And Neck Cancer – Pipeline by Laboratoires Pierre Fabre SA, H2 2016 178

Head And Neck Cancer – Pipeline by Lakewood-Amedex Inc, H2 2016 179

Head And Neck Cancer – Pipeline by Loxo Oncology, Inc., H2 2016 180

Head And Neck Cancer – Pipeline by Lytix Biopharma AS, H2 2016 181

Head And Neck Cancer – Pipeline by Mabion SA, H2 2016 182

Head And Neck Cancer – Pipeline by Mabtech Limited, H2 2016 183

Head And Neck Cancer – Pipeline by MacroGenics, Inc., H2 2016 184

Head And Neck Cancer – Pipeline by Marsala Biotech Inc., H2 2016 185

Head And Neck Cancer – Pipeline by Mateon Therapeutics Inc, H2 2016 186

Head And Neck Cancer – Pipeline by MaxiVAX SA, H2 2016 187

Head And Neck Cancer – Pipeline by Meabco A/S, H2 2016 188

Head And Neck Cancer – Pipeline by MedImmune, LLC, H2 2016 189

Head And Neck Cancer – Pipeline by Merck & Co., Inc., H2 2016 190

Head And Neck Cancer – Pipeline by Merck KGaA, H2 2016 191

Head And Neck Cancer – Pipeline by Merrimack Pharmaceuticals, Inc., H2 2016 192

Head And Neck Cancer – Pipeline by Millennium Pharmaceuticals Inc, H2 2016 193

Head And Neck Cancer – Pipeline by Mirati Therapeutics Inc., H2 2016 194

Head And Neck Cancer – Pipeline by Molecular Partners AG, H2 2016 195

Head And Neck Cancer – Pipeline by Moleculin Biotech Inc, H2 2016 196

Head And Neck Cancer – Pipeline by Molplex Ltd., H2 2016 197

Head And Neck Cancer – Pipeline by NanoCarrier Co., Ltd., H2 2016 198

Head And Neck Cancer – Pipeline by Natco Pharma Limited, H2 2016 199

Head And Neck Cancer – Pipeline by Neonc Technologies Inc, H2 2016 200

Head And Neck Cancer – Pipeline by Northwest Biotherapeutics, Inc., H2 2016 201

Head And Neck Cancer – Pipeline by Novartis AG, H2 2016 202

Head And Neck Cancer – Pipeline by Omnitura Therapeutics Inc., H2 2016 203

Head And Neck Cancer – Pipeline by Oncobiologics, Inc., H2 2016 204

Head And Neck Cancer – Pipeline by Oncolys BioPharma Inc, H2 2016 205

Head And Neck Cancer – Pipeline by Oncolytics Biotech Inc., H2 2016 206

Head And Neck Cancer – Pipeline by Onconova Therapeutics, Inc., H2 2016 207

Head And Neck Cancer – Pipeline by OncoSec Medical Incorporated, H2 2016 208

Head And Neck Cancer – Pipeline by Ono Pharmaceutical Co., Ltd., H2 2016 209

Head And Neck Cancer – Pipeline by Oryx GmbH & Co. KG, H2 2016 210

Head And Neck Cancer – Pipeline by Panacea Biotec Limited, H2 2016 211

Head And Neck Cancer – Pipeline by PCI Biotech Holding ASA, H2 2016 212

Head And Neck Cancer – Pipeline by PDS Biotechnology Corporation, H2 2016 213

Head And Neck Cancer – Pipeline by Pfizer Inc., H2 2016 214

Head And Neck Cancer – Pipeline by Pharma Mar, S.A., H2 2016 215

Head And Neck Cancer – Pipeline by Pique Therapeutics, H2 2016 216

Head And Neck Cancer – Pipeline by PlantForm Corporation, H2 2016 217

Head And Neck Cancer – Pipeline by Plexxikon Inc., H2 2016 218

Head And Neck Cancer – Pipeline by PNP Therapeutics, Inc., H2 2016 219

Head And Neck Cancer – Pipeline by Profectus BioSciences, Inc., H2 2016 220

Head And Neck Cancer – Pipeline by ProNAi Therapeutics, Inc., H2 2016 221

Head And Neck Cancer – Pipeline by Provectus Biopharmaceuticals, Inc., H2 2016 222

Head And Neck Cancer – Pipeline by R-Pharm, H2 2016 223

Head And Neck Cancer – Pipeline by Redx Pharma Plc, H2 2016 224

Head And Neck Cancer – Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016 225

Head And Neck Cancer – Pipeline by Sanofi, H2 2016 226

Head And Neck Cancer – Pipeline by Sapvax, H2 2016 227

Head And Neck Cancer – Pipeline by Sareum Holdings Plc, H2 2016 228

Head And Neck Cancer – Pipeline by Selecta Biosciences, Inc., H2 2016 229

Head And Neck Cancer – Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2016 230

Head And Neck Cancer – Pipeline by Shenzen SiBiono GeneTech Co., Ltd., H2 2016 231

Head And Neck Cancer – Pipeline by Shionogi & Co., Ltd., H2 2016 232

Head And Neck Cancer – Pipeline by Silence Therapeutics Plc, H2 2016 233

Head And Neck Cancer – Pipeline by Sillajen Biotherapeutics, H2 2016 234

Head And Neck Cancer – Pipeline by Sinil Pharmaceutical Co., Ltd, H2 2016 235

Head And Neck Cancer – Pipeline by SuviCa Inc., H2 2016 236

Head And Neck Cancer – Pipeline by Symphogen A/S, H2 2016 237

Head And Neck Cancer – Pipeline by SynCore Biotechnology Co., Ltd., H2 2016 238

Head And Neck Cancer – Pipeline by Taiwan Liposome Company, Ltd., H2 2016 239

Head And Neck Cancer – Pipeline by Takara Bio Inc., H2 2016 240

Head And Neck Cancer – Pipeline by Takis S.r.l., H2 2016 241

Head And Neck Cancer – Pipeline by Tara Immuno-Oncology Therapeutics LLC, H2 2016 242

Head And Neck Cancer – Pipeline by Tessa Therapeutics Pte Ltd, H2 2016 243

Head And Neck Cancer – Pipeline by Theravectys SA, H2 2016 244

Head And Neck Cancer – Pipeline by Tolero Pharmaceuticals, Inc., H2 2016 245

Head And Neck Cancer – Pipeline by TyrNovo Ltd., H2 2016 246

Head And Neck Cancer – Pipeline by UbiVac, LLC, H2 2016 247

Head And Neck Cancer – Pipeline by Vaccibody AS, H2 2016 248

Head And Neck Cancer – Pipeline by VasGene Therapeutics, Inc., H2 2016 249

Head And Neck Cancer – Pipeline by Vault Pharma Inc., H2 2016 250

Head And Neck Cancer – Pipeline by Vaxeal Holding SA, H2 2016 251

Head And Neck Cancer – Pipeline by VentiRx Pharmaceuticals, Inc., H2 2016 252

Head And Neck Cancer – Pipeline by Virttu Biologics Limited, H2 2016 253

Head And Neck Cancer – Pipeline by VLPbio, H2 2016 254

Head And Neck Cancer – Pipeline by VM Discovery, Inc., H2 2016 255

Head And Neck Cancer – Pipeline by Vyriad Inc, H2 2016 256

Head And Neck Cancer – Pipeline by Yabao Pharmaceutical Group Co., Ltd., H2 2016 257

Assessment by Monotherapy Products, H2 2016 258

Assessment by Combination Products, H2 2016 259

Number of Products by Stage and Target, H2 2016 261

Number of Products by Stage and Mechanism of Action, H2 2016 275

Number of Products by Stage and Route of Administration, H2 2016 290

Number of Products by Stage and Molecule Type, H2 2016 292

Head And Neck Cancer – Dormant Projects, H2 2016 1114

Head And Neck Cancer – Dormant Projects (Contd..1), H2 2016 1115

Head And Neck Cancer – Dormant Projects (Contd..2), H2 2016 1116

Head And Neck Cancer – Dormant Projects (Contd..3), H2 2016 1117

Head And Neck Cancer – Dormant Projects (Contd..4), H2 2016 1118

Head And Neck Cancer – Dormant Projects (Contd..5), H2 2016 1119

Head And Neck Cancer – Dormant Projects (Contd..6), H2 2016 1120

Head And Neck Cancer – Dormant Projects (Contd..7), H2 2016 1121

Head And Neck Cancer – Dormant Projects (Contd..8), H2 2016 1122

Head And Neck Cancer – Dormant Projects (Contd..9), H2 2016 1123

Head And Neck Cancer – Dormant Projects (Contd..10), H2 2016 1124

Head And Neck Cancer – Dormant Projects (Contd..11), H2 2016 1125

Head And Neck Cancer – Dormant Projects (Contd..12), H2 2016 1126

Head And Neck Cancer – Dormant Projects (Contd..13), H2 2016 1127

Head And Neck Cancer – Dormant Projects (Contd..14), H2 2016 1128

Head And Neck Cancer – Dormant Projects (Contd..15), H2 2016 1129

Head And Neck Cancer – Discontinued Products, H2 2016 1130

Head And Neck Cancer – Discontinued Products (Contd..1), H2 2016 1131

Head And Neck Cancer – Discontinued Products (Contd..2), H2 2016 1132

List of Figures

List of Figures

Number of Products under Development for Head And Neck Cancer, H2 2016 44

Number of Products under Development for Head And Neck Cancer – Comparative Analysis, H2 2016 45

Number of Products under Development by Companies, H2 2016 46

Number of Products under Investigation by Universities/Institutes, H2 2016 60

Comparative Analysis by Late Stage Development, H2 2016 62

Comparative Analysis by Clinical Stage Development, H2 2016 63

Comparative Analysis by Early Stage Products, H2 2016 64

Assessment by Monotherapy Products, H2 2016 258

Assessment by Combination Products, H2 2016 259

Number of Products by Top 10 Targets, H2 2016 260

Number of Products by Stage and Top 10 Targets, H2 2016 260

Number of Products by Top 10 Mechanism of Actions, H2 2016 274

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 274

Number of Products by Top 10 Routes of Administration, H2 2016 289

Number of Products by Stage and Top 10 Routes of Administration, H2 2016 289

Number of Products by Top 10 Molecule Types, H2 2016 291

Number of Products by Stage and Top 10 Molecule Types, H2 2016 291

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports